MetaADEDB 2.0 @ LMMD
ledipasvir, sofosbuvir drug combination
(YWRYBUCQWKGONV-CABNZSRHSA-N)
Structure
SMILES
CC(OC(=O)[C@@H](N[P@](=O)(Oc1ccccc1)OC[C@H]1O[C@H]([C@]([C@@H]1O)(C)F)n1ccc(=O)[nH]c1=O)C)C.COC(=O)N[C@H](C(=O)N1CC2(C[C@H]1c1ncc([nH]1)c1ccc3c(c1)C(F)(F)c1c3ccc(c1)c1ccc3c(c1)[nH]c(n3)[C@@H]1[C@H]3CC[C@@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C3)CC2)C(C)C
Molecular Formula:
C71H83F3N11O15P
Molecular Weight:
1418.450
Log P:
11.3123
Hydrogen Bond Acceptor:
23
Hydrogen Bond Donor:
7
TPSA:
342.63
CAS Number(s):
N/A
Synonym(s)
1.
ledipasvir, sofosbuvir drug combination
2.
Harvoni
3.
ledipasvir - sofosbuvir
External Link(s)
MeSHC000595958
PubChem Compound72734365
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 3447
Canada Vigilance: 7
Canada Vigilance
US FAERS
2HeadacheFAERS: 3137
Canada Vigilance: 10
Canada Vigilance
US FAERS
3NauseaFAERS: 907
Canada Vigilance: 3
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 508
Canada Vigilance: 38
Canada Vigilance
US FAERS
5Drug dose omissionFAERS: 375US FAERS
6Hepatitis CFAERS: 356
Canada Vigilance: 20
Canada Vigilance
US FAERS
7DizzinessFAERS: 288
Canada Vigilance: 1
Canada Vigilance
US FAERS
8ConstipationFAERS: 234
Canada Vigilance: 1
Canada Vigilance
US FAERS
9VomitingFAERS: 224
Canada Vigilance: 5
Canada Vigilance
US FAERS
10ArthralgiaFAERS: 217
Canada Vigilance: 2
Canada Vigilance
US FAERS
11PruritusFAERS: 217
Canada Vigilance: 1
Canada Vigilance
US FAERS
12DyspepsiaFAERS: 189
Canada Vigilance: 1
Canada Vigilance
US FAERS
13treatment failureFAERS: 182
Canada Vigilance: 15
Canada Vigilance
US FAERS
14PainFAERS: 181
Canada Vigilance: 2
Canada Vigilance
US FAERS
15Abdominal discomfortFAERS: 176US FAERS
16AnxietyFAERS: 165
Canada Vigilance: 1
Canada Vigilance
US FAERS
17AstheniaFAERS: 157
Canada Vigilance: 2
Canada Vigilance
US FAERS
18MyalgiaFAERS: 151US FAERS
19AlopeciaFAERS: 132US FAERS
20NasopharyngitisFAERS: 128
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Feeling abnormalFAERS: 108
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Back PainFAERS: 95
Canada Vigilance: 2
Canada Vigilance
US FAERS
23Weight decreasedFAERS: 92
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Memory impairmentFAERS: 91
Canada Vigilance: 1
Canada Vigilance
US FAERS
25SomnolenceFAERS: 85US FAERS
26MalaiseFAERS: 83
Canada Vigilance: 6
Canada Vigilance
US FAERS
27Hepatitis C virus test positiveFAERS: 80
Canada Vigilance: 4
Canada Vigilance
US FAERS
28Abdominal PainFAERS: 75
Canada Vigilance: 4
Canada Vigilance
US FAERS
29Dry skinFAERS: 73US FAERS
30Peripheral swellingFAERS: 69
Canada Vigilance: 3
Canada Vigilance
US FAERS
31AscitesFAERS: 67
Canada Vigilance: 3
Canada Vigilance
US FAERS
32FlatulenceFAERS: 63US FAERS
33TinnitusFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Genotype drug resistance test positiveFAERS: 59US FAERS
35Chest PainFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Maternal exposure during pregnancyFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
37InfluenzaFAERS: 54US FAERS
38OverdoseFAERS: 52US FAERS
39PneumoniaFAERS: 51
Canada Vigilance: 4
Canada Vigilance
US FAERS
40Urinary tract infectionFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
41AmnesiaFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Visual ImpairmentFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Oropharyngeal painFAERS: 46US FAERS
44DehydrationFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Therapy cessationFAERS: 45US FAERS
46PalpitationsFAERS: 44US FAERS
47Therapeutic response unexpectedFAERS: 44
Canada Vigilance: 4
Canada Vigilance
US FAERS
48DysgeusiaFAERS: 40US FAERS
49Accidental overdoseFAERS: 39US FAERS
50EpistaxisFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Blood glucose increasedFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
52Joint swellingFAERS: 38US FAERS
53Product dose omissionFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
54Unevaluable eventFAERS: 38US FAERS
55SinusitisFAERS: 37US FAERS
56Chest discomfortFAERS: 36US FAERS
57Intentional product use issueFAERS: 35US FAERS
58ChillsFAERS: 34US FAERS
59TremorFAERS: 34
Canada Vigilance: 3
Canada Vigilance
US FAERS
60ThirstFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
61StomatitisFAERS: 32US FAERS
62ChromaturiaFAERS: 31US FAERS
63Myocardial InfarctionFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
64Wrong technique in product usage processFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Acute kidney injuryFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Cerebrovascular accidentFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
67Musculoskeletal PainFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
68SyncopeFAERS: 29US FAERS
69Extra dose administeredFAERS: 28US FAERS
70VertigoFAERS: 27US FAERS
71Viral mutation identifiedFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
72HypersensitivityFAERS: 26US FAERS
73Neck PainFAERS: 26US FAERS
74Atrial FibrillationFAERS: 25US FAERS
75Blood creatinine increasedFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
76HypersomniaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
77Intentional dose omissionFAERS: 25US FAERS
78UrticariaFAERS: 25US FAERS
79Bone painFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Burning sensationFAERS: 24US FAERS
81ErythemaFAERS: 24US FAERS
82SepsisFAERS: 24
Canada Vigilance: 3
Canada Vigilance
US FAERS
83Product use issueFAERS: 23US FAERS
84Mood swingsFAERS: 22US FAERS
85AgitationFAERS: 21US FAERS
86AngerFAERS: 21US FAERS
87BronchitisFAERS: 21US FAERS
88DisorientationFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
89LethargyFAERS: 21US FAERS
90Lip swellingFAERS: 21US FAERS
91Musculoskeletal stiffnessFAERS: 21US FAERS
92Night sweatsFAERS: 21US FAERS
93PancreatitisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Hepatic EncephalopathyFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Hepatitis BFAERS: 20US FAERS
96Incorrect drug administration durationFAERS: 20US FAERS
97AcneFAERS: 19US FAERS
98Middle insomniaFAERS: 19US FAERS
99Alanine Aminotransferase IncreasedFAERS: 18US FAERS
100ArthritisFAERS: 18US FAERS
101BradycardiaFAERS: 18US FAERS
102Depressed moodFAERS: 18US FAERS
103Inappropriate schedule of drug administrationFAERS: 18US FAERS
104NephrolithiasisFAERS: 18US FAERS
105Ammonia increasedFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
106NeuralgiaFAERS: 17US FAERS
107PsoriasisFAERS: 17US FAERS
108ThrombocytopeniaFAERS: 17US FAERS
109ToothacheFAERS: 17US FAERS
110Aspartate Aminotransferase IncreasedFAERS: 16US FAERS
111GoutFAERS: 16US FAERS
112StressFAERS: 16US FAERS
113Diabetes MellitusFAERS: 15US FAERS
114Impaired work abilityFAERS: 15US FAERS
115Product difficult to swallowFAERS: 15US FAERS
116Eye painFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
117Initial insomniaFAERS: 14US FAERS
118RestlessnessFAERS: 14US FAERS
119SwellingFAERS: 14US FAERS
120White blood cell count decreasedFAERS: 14US FAERS
121AngioedemaFAERS: 13US FAERS
122Drug resistanceFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
123LymphadenopathyFAERS: 13US FAERS
124PhotophobiaFAERS: 13US FAERS
125Productive CoughFAERS: 13US FAERS
126Rash erythematousFAERS: 13US FAERS
127CataractFAERS: 12US FAERS
128CryingFAERS: 12US FAERS
129DysuriaFAERS: 12US FAERS
130EczemaFAERS: 12US FAERS
131Emotional disorderFAERS: 12US FAERS
132Feeling ColdFAERS: 12US FAERS
133InfectionFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
134NervousnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Product use complaintFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
136jaundiceFAERS: 12US FAERS
137Blood creatine phosphokinase increasedFAERS: 11US FAERS
138Blood glucose decreasedFAERS: 11US FAERS
139Blood urine presentFAERS: 11US FAERS
140DiplopiaFAERS: 11US FAERS
141ParanoiaFAERS: 11US FAERS
142Product packaging quantity issueFAERS: 11US FAERS
143Respiratory tract congestionFAERS: 11US FAERS
144Skin UlcerFAERS: 11US FAERS
145Suicide attemptFAERS: 11US FAERS
146Therapy non-responderFAERS: 11US FAERS
147ArthropathyFAERS: 10US FAERS
148HypotensionFAERS: 10US FAERS
149Incorrect dose administeredFAERS: 10US FAERS
150LymphomaFAERS: 10US FAERS
151Blood cholesterol increasedFAERS: 9US FAERS
152Cold sweatFAERS: 9US FAERS
153Depressed Level of ConsciousnessFAERS: 9US FAERS
154DiscomfortFAERS: 9US FAERS
155Eye irritationFAERS: 9US FAERS
156HungerFAERS: 9US FAERS
157InflammationFAERS: 9US FAERS
158Pancreatic carcinomaFAERS: 9US FAERS
159PancytopeniaFAERS: 9US FAERS
160Product quality issueFAERS: 9US FAERS
161TachycardiaFAERS: 9US FAERS
162Tooth InfectionFAERS: 9US FAERS
163Transaminases increasedFAERS: 9US FAERS
164AsthmaFAERS: 8US FAERS
165Back disorderFAERS: 8US FAERS
166Blood potassium decreasedFAERS: 8US FAERS
167CellulitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Cerebral InfarctionFAERS: 8US FAERS
169DeafnessFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Feeling jitteryFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
171FlushingFAERS: 8US FAERS
172FractureFAERS: 8US FAERS
173HyperthyroidismFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Limb discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Loss of personal independence in daily activitiesFAERS: 8US FAERS
176Mental status changesFAERS: 8US FAERS
177Musculoskeletal chest painFAERS: 8US FAERS
178PregnancyFAERS: 8US FAERS
179PresyncopeFAERS: 8US FAERS
180Product storage errorFAERS: 8US FAERS
181Pulmonary congestionFAERS: 8US FAERS
182Renal painFAERS: 8US FAERS
183Viral load increasedFAERS: 8US FAERS
184Vitreous floatersFAERS: 8US FAERS
185Autoimmune hepatitisFAERS: 7US FAERS
186BlindnessFAERS: 7US FAERS
187Blood potassium increasedFAERS: 7US FAERS
188CystitisFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
189Disease recurrenceFAERS: 7US FAERS
190Facial paralysisFAERS: 7US FAERS
191Lichen PlanusFAERS: 7US FAERS
192Mental impairmentFAERS: 7US FAERS
193Mouth swellingFAERS: 7US FAERS
194Muscle strainFAERS: 7US FAERS
195Muscle tightnessFAERS: 7US FAERS
196Ocular icterusFAERS: 7US FAERS
197Poor quality sleepFAERS: 7US FAERS
198Respiratory FailureFAERS: 7US FAERS
199RetchingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
200Rheumatoid ArthritisFAERS: 7US FAERS
201Septic ShockFAERS: 7US FAERS
202SluggishnessFAERS: 7US FAERS
203Throat irritationFAERS: 7US FAERS
204Urinary IncontinenceFAERS: 7US FAERS
205Viral upper respiratory tract infectionFAERS: 7US FAERS
206WheezingFAERS: 7US FAERS
207AbasiaFAERS: 6US FAERS
208Arthropod biteFAERS: 6US FAERS
209CholangiocarcinomaFAERS: 6US FAERS
210Creatinine renal clearance decreasedFAERS: 6US FAERS
211DementiaFAERS: 6US FAERS
212Drug dispensing errorFAERS: 6US FAERS
213DysphoniaFAERS: 6US FAERS
214EructationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
215Gastric infectionFAERS: 6US FAERS
216Gastric ulcerFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
217GastritisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
218HemiplegiaFAERS: 6US FAERS
219Intestinal ObstructionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
220Lower respiratory tract infectionFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
221Multiple allergiesFAERS: 6US FAERS
222NeutropeniaFAERS: 6US FAERS
223OsteomyelitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
224Paranasal sinus discomfortFAERS: 6US FAERS
225Product size issueFAERS: 6US FAERS
226SciaticaFAERS: 6US FAERS
227SplenomegalyFAERS: 6US FAERS
228Urinary RetentionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
229VIIth nerve paralysisFAERS: 6US FAERS
230Wrong scheduleFAERS: 6US FAERS
231nervous system disorderFAERS: 6US FAERS
232Activities of daily living impairedFAERS: 5US FAERS
233ApathyFAERS: 5US FAERS
234AphasiaFAERS: 5US FAERS
235AppendicitisFAERS: 5US FAERS
236Blood alkaline phosphatase increasedFAERS: 5US FAERS
237Blood pressure fluctuationFAERS: 5US FAERS
238Blood sodium decreasedFAERS: 5US FAERS
239Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
240Clostridium difficile infectionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
241DeliriumFAERS: 5US FAERS
242DysarthriaFAERS: 5US FAERS
243Economic problemFAERS: 5US FAERS
244EndocarditisFAERS: 5US FAERS
245Erectile dysfunctionFAERS: 5US FAERS
246Food PoisoningFAERS: 5US FAERS
247Hepatitis B virus test positiveFAERS: 5US FAERS
248Hepatitis C RNA increasedFAERS: 5US FAERS
249HyperchlorhydriaFAERS: 5US FAERS
250Increased tendency to bruiseFAERS: 5US FAERS
251Intentional product misuseFAERS: 5US FAERS
252MenorrhagiaFAERS: 5US FAERS
253Oral candidiasisFAERS: 5US FAERS
254Oral painFAERS: 5US FAERS
255PneumothoraxFAERS: 5US FAERS
256Pulmonary EmbolismFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
257RhabdomyolysisFAERS: 5US FAERS
258Skin lesionFAERS: 5US FAERS
259Therapy changeFAERS: 5US FAERS
260ThrombosisFAERS: 5US FAERS
261UlcerFAERS: 5US FAERS
262BedriddenFAERS: 4US FAERS
263Blood glucose abnormalFAERS: 4US FAERS
264Blood urea increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Cardiac ArrestFAERS: 4US FAERS
266CholelithiasisFAERS: 4US FAERS
267ColitisFAERS: 4US FAERS
268ConjunctivitisFAERS: 4US FAERS
269CyanosisFAERS: 4US FAERS
270CystFAERS: 4US FAERS
271Drug screen false positiveFAERS: 4US FAERS
272Drug screen positiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Ear discomfortFAERS: 4US FAERS
274Emotional distressFAERS: 4US FAERS
275EpilepsyFAERS: 4US FAERS
276Erythema MultiformeFAERS: 4US FAERS
277FibromyalgiaFAERS: 4US FAERS
278Flank PainFAERS: 4US FAERS
279Food cravingFAERS: 4US FAERS
280Full blood count decreasedFAERS: 4US FAERS
281General physical health deteriorationFAERS: 4US FAERS
282Head discomfortFAERS: 4US FAERS
283Hepatitis B DNA increasedFAERS: 4US FAERS
284Hepatitis C RNA positiveFAERS: 4US FAERS
285HerniaFAERS: 4US FAERS
286Hypertensive crisisFAERS: 4US FAERS
287HypophagiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
288IleusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
289Immune thrombocytopenic purpuraFAERS: 4US FAERS
290Incorrect product storageFAERS: 4US FAERS
291Low density lipoprotein increasedFAERS: 4US FAERS
292Lower respiratory tract congestionFAERS: 4US FAERS
293MeningitisFAERS: 4US FAERS
294Metabolic acidosisFAERS: 4US FAERS
295Muscle FatigueFAERS: 4US FAERS
296OsteoporosisFAERS: 4US FAERS
297Pain of skinFAERS: 4US FAERS
298Portal Vein ThrombosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
299Product availability issueFAERS: 4US FAERS
300Pulmonary function test decreasedFAERS: 4US FAERS
301SarcoidosisFAERS: 4US FAERS
302SneezingFAERS: 4US FAERS
303Sudden deathFAERS: 4US FAERS
304TransplantFAERS: 4US FAERS
305VasculitisFAERS: 4US FAERS
306VitiligoFAERS: 4US FAERS
307Abdominal rigidityFAERS: 3US FAERS
308Acute myocardial infarctionFAERS: 3US FAERS
309Altered state of consciousnessFAERS: 3US FAERS
310Blood magnesium decreasedFAERS: 3US FAERS
311Blood thyroid stimulating hormone increasedFAERS: 3US FAERS
312Cardiac FlutterFAERS: 3US FAERS
313Carpal Tunnel SyndromeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
314ChokingFAERS: 3US FAERS
315CholecystitisFAERS: 3US FAERS
316Completed SuicideFAERS: 3US FAERS
317Deep Vein ThrombosisFAERS: 3US FAERS
318Dental cariesFAERS: 3US FAERS
319DermatitisFAERS: 3US FAERS
320Diabetic KetoacidosisFAERS: 3US FAERS
321Disseminated Intravascular CoagulationFAERS: 3US FAERS
322DiverticulitisFAERS: 3US FAERS
323Drug abuseFAERS: 3US FAERS
324Drug administration errorFAERS: 3US FAERS
325DysplasiaFAERS: 3US FAERS
326Epigastric discomfortFAERS: 3US FAERS
327Euphoric moodFAERS: 3US FAERS
328Facial PainFAERS: 3US FAERS
329Febrile NeutropeniaFAERS: 3US FAERS
330Fluid overloadFAERS: 3US FAERS
331FrustrationFAERS: 3US FAERS
332Gastrointestinal motility disorderFAERS: 3US FAERS
333General physical condition abnormalFAERS: 3US FAERS
334Genital HerpesFAERS: 3US FAERS
335GlossitisFAERS: 3US FAERS
336Guillain-Barre SyndromeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
337HepatitisFAERS: 3US FAERS
338HordeolumFAERS: 3US FAERS
339IncoherentFAERS: 3US FAERS
340Injection site painFAERS: 3US FAERS
341Insurance issueFAERS: 3US FAERS
342Irritable Bowel SyndromeFAERS: 3US FAERS
343Joint injuryFAERS: 3US FAERS
344Joint stiffnessFAERS: 3US FAERS
345LacerationFAERS: 3US FAERS
346LeukopeniaFAERS: 3US FAERS
347Lipase increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
348Localised intraabdominal fluid collectionFAERS: 3US FAERS
349Loose toothFAERS: 3US FAERS
350Medication residue presentFAERS: 3US FAERS
351Metastatic NeoplasmFAERS: 3US FAERS
352Multiple SclerosisFAERS: 3US FAERS
353Musculoskeletal discomfortFAERS: 3US FAERS
354Myasthenia GravisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Nasal discomfortFAERS: 3US FAERS
356Negative thoughtsFAERS: 3US FAERS
357Nephrotic SyndromeFAERS: 3US FAERS
358Nerve injuryFAERS: 3US FAERS
359Nipple painFAERS: 3US FAERS
360OnychomycosisFAERS: 3US FAERS
361PericarditisFAERS: 3US FAERS
362PolydipsiaFAERS: 3US FAERS
363Porphyria non-acuteFAERS: 3US FAERS
364Portal hypertensive gastropathyFAERS: 3US FAERS
365Product container seal issueFAERS: 3US FAERS
366ProteinuriaFAERS: 3US FAERS
367PurpuraFAERS: 3US FAERS
368Restless Legs SyndromeFAERS: 3US FAERS
369Retinal DetachmentFAERS: 3US FAERS
370Sexual DysfunctionFAERS: 3US FAERS
371Sinus headacheFAERS: 3US FAERS
372Supraventricular tachycardiaFAERS: 3US FAERS
373Tooth ExtractionFAERS: 3US FAERS
374Wrong technique in drug usage processFAERS: 3US FAERS
375furuncleFAERS: 3US FAERS
376AbscessFAERS: 2US FAERS
377Accidental exposure to productFAERS: 2US FAERS
378Adnexa uteri painFAERS: 2US FAERS
379AgeusiaFAERS: 2US FAERS
380Ammonia abnormalFAERS: 2US FAERS
381Amylase increasedFAERS: 2US FAERS
382Angina PectorisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
383Animal biteFAERS: 2US FAERS
384AphoniaFAERS: 2US FAERS
385AsthenopiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
386Atrial FlutterFAERS: 2US FAERS
387Autoimmune thyroiditisFAERS: 2US FAERS
388Bacterial VaginosisFAERS: 2US FAERS
389Basal cell carcinomaFAERS: 2US FAERS
390Biliary ColicFAERS: 2US FAERS
391BlepharospasmFAERS: 2US FAERS
392Blood albumin decreasedFAERS: 2US FAERS
393Blood glucose fluctuationFAERS: 2US FAERS
394Blood pressure inadequately controlledFAERS: 2US FAERS
395Blood sodium abnormalFAERS: 2US FAERS
396Blood testosterone decreasedFAERS: 2US FAERS
397Blood triglycerides increasedFAERS: 2US FAERS
398Bowel movement irregularityFAERS: 2US FAERS
399BruxismFAERS: 2US FAERS
400Cardioactive drug level increasedFAERS: 2US FAERS
401Cerebral disorderFAERS: 2US FAERS
402CheilitisFAERS: 2US FAERS
403Clostridium difficile colitisFAERS: 2US FAERS
404Cluster HeadacheFAERS: 2US FAERS
405ColectomyFAERS: 2US FAERS
406Compression fractureFAERS: 2US FAERS
407Cytomegalovirus test positiveFAERS: 2US FAERS
408DemyelinationFAERS: 2US FAERS
409Diabetes mellitus inadequate controlFAERS: 2US FAERS
410Diastolic dysfunctionFAERS: 2US FAERS
411Diffuse Large B-Cell LymphomaFAERS: 2US FAERS
412Disease ProgressionFAERS: 2US FAERS
413Diuretic therapyFAERS: 2US FAERS
414Drug level increasedFAERS: 2US FAERS
415Drug prescribing errorFAERS: 2US FAERS
416Drug withdrawal syndromeFAERS: 2US FAERS
417Electrocardiogram RR interval prolongedFAERS: 2US FAERS
418EncephalitisFAERS: 2US FAERS
419Endodontic procedureFAERS: 2US FAERS
420Enzyme level increasedFAERS: 2US FAERS
421ErysipelasFAERS: 2US FAERS
422Erythema NodosumFAERS: 2US FAERS
423Excessive eye blinkingFAERS: 2US FAERS
424Exfoliative rashFAERS: 2US FAERS
425False positive investigation resultFAERS: 2US FAERS
426Feeding tube userFAERS: 2US FAERS
427FibrosisFAERS: 2US FAERS
428FolliculitisFAERS: 2US FAERS
429FormicationFAERS: 2US FAERS
430Frustration tolerance decreasedFAERS: 2US FAERS
431Fulminant type 1 diabetes mellitusFAERS: 2US FAERS
432Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
433Gastrointestinal PainFAERS: 2US FAERS
434Gastrointestinal sounds abnormalFAERS: 2US FAERS
435General symptomFAERS: 2US FAERS
436GingivitisFAERS: 2US FAERS
437GlaucomaFAERS: 2US FAERS
438Hepatic cancer metastaticFAERS: 2US FAERS
439Hepatitis C RNA fluctuationFAERS: 2US FAERS
440Hepatitis C RNAFAERS: 2US FAERS
441Hepatitis C antibody positiveFAERS: 2US FAERS
442HepatomegalyFAERS: 2US FAERS
443Hepatorenal SyndromeFAERS: 2US FAERS
444HyperphagiaFAERS: 2US FAERS
445HypothyroidismFAERS: 2US FAERS
446Immune Reconstitution Inflammatory SyndromeFAERS: 2US FAERS
447Immune-mediated adverse reactionFAERS: 2US FAERS
448ImpetigoFAERS: 2US FAERS
449Inappropriate schedule of product administrationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
450Infrequent bowel movementsFAERS: 2US FAERS
451IridocyclitisFAERS: 2US FAERS
452LabyrinthitisFAERS: 2US FAERS
453Lactose IntoleranceFAERS: 2US FAERS
454Limb injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
455LymphocytosisFAERS: 2US FAERS
456MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
457MalabsorptionFAERS: 2US FAERS
458Manufacturing product shipping issueFAERS: 2US FAERS
459Meniscus injuryFAERS: 2US FAERS
460Mononeuropathy MultiplexFAERS: 2US FAERS
461Motion SicknessFAERS: 2US FAERS
462N-terminal prohormone brain natriuretic peptide increasedFAERS: 2US FAERS
463Nail InfectionFAERS: 2US FAERS
464Nerve Root CompressionFAERS: 2US FAERS
465Neutrophil count decreasedFAERS: 2US FAERS
466Optic NeuritisFAERS: 2US FAERS
467Oropharyngeal discomfortFAERS: 2US FAERS
468PharyngitisFAERS: 2US FAERS
469Physical assaultFAERS: 2US FAERS
470Platelet count abnormalFAERS: 2US FAERS
471PoisoningFAERS: 2US FAERS
472PolyarthritisFAERS: 2US FAERS
473PolyneuropathyFAERS: 2US FAERS
474Post procedural infectionFAERS: 2US FAERS
475Product counterfeitFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
476Product physical issueFAERS: 2US FAERS
477Product taste abnormalFAERS: 2US FAERS
478Protein total increasedFAERS: 2US FAERS
479Protein urine presentFAERS: 2US FAERS
480Pulmonary HypertensionFAERS: 2US FAERS
481Pulmonary thrombosisFAERS: 2US FAERS
482RadiculopathyFAERS: 2US FAERS
483Reflux gastritisFAERS: 2US FAERS
484ScabFAERS: 2US FAERS
485SchizophreniaFAERS: 2US FAERS
486Skin reactionFAERS: 2US FAERS
487Stress at workFAERS: 2US FAERS
488Subcutaneous AbscessFAERS: 2US FAERS
489Sudden Cardiac DeathFAERS: 2US FAERS
490SunburnFAERS: 2US FAERS
491Temperature intoleranceFAERS: 2US FAERS
492Tension HeadacheFAERS: 2US FAERS
493ThyroiditisFAERS: 2US FAERS
494Time perception alteredFAERS: 2US FAERS
495Tooth LossFAERS: 2US FAERS
496Toxicity to various agentsFAERS: 2US FAERS
497Transplant evaluationFAERS: 2US FAERS
498TrichorrhexisFAERS: 2US FAERS
499Upper respiratory tract congestionFAERS: 2US FAERS
500Upper-airway cough syndromeFAERS: 2US FAERS
501UreterolithiasisFAERS: 2US FAERS
502UveitisFAERS: 2US FAERS
503Viral load decreasedFAERS: 2US FAERS
504Viral test positiveFAERS: 2US FAERS
505Virologic failureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
506Vitamin D DeficiencyFAERS: 2US FAERS
507Vitreous DetachmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
508Vulvovaginal drynessFAERS: 2US FAERS
509Vulvovaginal pruritusFAERS: 2US FAERS
510Walking aid userFAERS: 2US FAERS
511Water IntoxicationFAERS: 2US FAERS
512Wrong drug administeredFAERS: 2US FAERS
513Wrong product administeredFAERS: 2US FAERS
514Abnormal clotting factorFAERS: 1US FAERS
515AbuliaFAERS: 1US FAERS
516AchlorhydriaFAERS: 1US FAERS
517Acute Coronary SyndromeFAERS: 1US FAERS
518Adverse eventFAERS: 1US FAERS
519Alanine aminotransferase abnormalFAERS: 1US FAERS
520Alanine aminotransferase decreasedFAERS: 1US FAERS
521Albumin globulin ratio abnormalFAERS: 1US FAERS
522Alcohol abuseFAERS: 1US FAERS
523Alcohol interactionFAERS: 1US FAERS
524Alcohol problemFAERS: 1US FAERS
525Alcohol withdrawal syndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
526Alopecia universalisFAERS: 1US FAERS
527Alpha 1 foetoprotein decreasedFAERS: 1US FAERS
528Alpha-2 macroglobulin increasedFAERS: 1US FAERS
529Amnestic DisorderFAERS: 1US FAERS
530AmputationFAERS: 1US FAERS
531Amyotrophic Lateral SclerosisFAERS: 1US FAERS
532Anal fungal infectionFAERS: 1US FAERS
533Anal infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
534AngiomyolipomaFAERS: 1US FAERS
535Animal scratchFAERS: 1US FAERS
536Ankle FractureFAERS: 1US FAERS
537Anorectal discomfortFAERS: 1US FAERS
538Anorexia NervosaFAERS: 1US FAERS
539AnorgasmiaFAERS: 1US FAERS
540AnosmiaFAERS: 1US FAERS
541Antibody test abnormalFAERS: 1US FAERS
542Antibody test positiveFAERS: 1US FAERS
543Anticonvulsant drug level decreasedFAERS: 1US FAERS
544Aortic stent insertionFAERS: 1US FAERS
545AphagiaFAERS: 1US FAERS
546Arthropod stingFAERS: 1US FAERS
547Aspartate aminotransferase decreasedFAERS: 1US FAERS
548Atrioventricular BlockFAERS: 1US FAERS
549Beta 2 microglobulin increasedFAERS: 1US FAERS
550Binge DrinkingFAERS: 1US FAERS
551Bipolar DisorderFAERS: 1US FAERS
552Bipolar I disorderFAERS: 1US FAERS
553Bladder NeoplasmFAERS: 1US FAERS
554Bladder painFAERS: 1US FAERS
555Blood alkaline phosphatase abnormalFAERS: 1US FAERS
556Blood bilirubin abnormalFAERS: 1US FAERS
557Blood cholesterol abnormalFAERS: 1US FAERS
558Blood count abnormalFAERS: 1US FAERS
559Blood creatine increasedFAERS: 1US FAERS
560Blood creatine phosphokinase abnormalFAERS: 1US FAERS
561Blood creatinine abnormalFAERS: 1US FAERS
562Blood creatinine decreasedFAERS: 1US FAERS
563Blood electrolytes abnormalFAERS: 1US FAERS
564Blood fibrinogen decreasedFAERS: 1US FAERS
565Blood glucose normalFAERS: 1US FAERS
566Blood iron abnormalFAERS: 1US FAERS
567Blood iron decreasedFAERS: 1US FAERS
568Blood lactate dehydrogenase increasedFAERS: 1US FAERS
569Blood sodium increasedFAERS: 1US FAERS
570Blood testosterone increasedFAERS: 1US FAERS
571Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
572Blood triglycerides abnormalFAERS: 1US FAERS
573Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
574Breast cancer recurrentFAERS: 1US FAERS
575Breast tendernessFAERS: 1US FAERS
576BronchospasmFAERS: 1US FAERS
577Burning Mouth SyndromeFAERS: 1US FAERS
578C-reactive protein abnormalFAERS: 1US FAERS
579CD8 lymphocytes abnormalFAERS: 1US FAERS
580CachexiaFAERS: 1US FAERS
581CalcinosisFAERS: 1US FAERS
582Cardiac DeathFAERS: 1US FAERS
583Cardiac discomfortFAERS: 1US FAERS
584Cataract operationFAERS: 1US FAERS
585Cerebral ThrombosisFAERS: 1US FAERS
586Cervicobrachial syndromeFAERS: 1US FAERS
587ChemotherapyFAERS: 1US FAERS
588ChondrosarcomaFAERS: 1US FAERS
589Coating in mouthFAERS: 1US FAERS
590Coma scale abnormalFAERS: 1US FAERS
591Compulsive lip bitingFAERS: 1US FAERS
592Congenital cystic kidney diseaseFAERS: 1US FAERS
593Conjunctival pigmentationFAERS: 1US FAERS
594Coronary angioplastyFAERS: 1US FAERS
595Coronary artery embolismFAERS: 1US FAERS
596Corrective lens userFAERS: 1US FAERS
597Cortical laminar necrosisFAERS: 1US FAERS
598Counterfeit product administeredFAERS: 1US FAERS
599Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
600Cryoglobulins presentFAERS: 1US FAERS
601Crystal urine presentFAERS: 1US FAERS
602Cyst drainageFAERS: 1US FAERS
603Dark circles under eyesFAERS: 1US FAERS
604Delusional disorder, unspecified typeFAERS: 1US FAERS
605Device FailureFAERS: 1US FAERS
606Diffuse large B-cell lymphoma recurrentFAERS: 1US FAERS
607DisabilityFAERS: 1US FAERS
608DiverticulumFAERS: 1US FAERS
609DroolingFAERS: 1US FAERS
610Drug DependenceFAERS: 1US FAERS
611Drug abuserFAERS: 1US FAERS
612Drug effect incompleteFAERS: 1US FAERS
613Duodenal ulcer perforationFAERS: 1US FAERS
614DuodenitisFAERS: 1US FAERS
615DyscalculiaFAERS: 1US FAERS
616DysgraphiaFAERS: 1US FAERS
617DyslaliaFAERS: 1US FAERS
618DystoniaFAERS: 1US FAERS
619Electrocardiogram abnormalFAERS: 1US FAERS
620Electrolyte depletionFAERS: 1US FAERS
621Electrolyte imbalanceFAERS: 1US FAERS
622Elevated moodFAERS: 1US FAERS
623Emergency CareFAERS: 1US FAERS
624Emotional povertyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
625EnchondromatosisFAERS: 1US FAERS
626EnteritisFAERS: 1US FAERS
627Enterocolitis viralFAERS: 1US FAERS
628EnterocolitisFAERS: 1US FAERS
629EnthesopathyFAERS: 1US FAERS
630Ex-tobacco userFAERS: 1US FAERS
631Expired product administeredFAERS: 1US FAERS
632Exposure during breast feedingFAERS: 1US FAERS
633Exposure via body fluidFAERS: 1US FAERS
634Exposure via partnerFAERS: 1US FAERS
635Eye BurnsFAERS: 1US FAERS
636Eye InfectionFAERS: 1US FAERS
637Eyelid margin crustingFAERS: 1US FAERS
638Facial ParesisFAERS: 1US FAERS
639Facial wastingFAERS: 1US FAERS
640Fat redistributionFAERS: 1US FAERS
641Feeling of body temperature changeFAERS: 1US FAERS
642Fibrillary glomerulonephritisFAERS: 1US FAERS
643Fixed eruptionFAERS: 1US FAERS
644Fluid imbalanceFAERS: 1US FAERS
645Gait inabilityFAERS: 1US FAERS
646GastrectomyFAERS: 1US FAERS
647Gastric BypassFAERS: 1US FAERS
648Gastric FistulaFAERS: 1US FAERS
649Gastric pH increasedFAERS: 1US FAERS
650GastroenteritisFAERS: 1US FAERS
651Gastrointestinal hypomotilityFAERS: 1US FAERS
652Gastrointestinal somatic symptom disorderFAERS: 1US FAERS
653GastrostomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Gingival RecessionFAERS: 1US FAERS
655Granulocyte count increasedFAERS: 1US FAERS
656Granuloma AnnulareFAERS: 1US FAERS
657Grip strength decreasedFAERS: 1US FAERS
658Hallucinations, mixedFAERS: 1US FAERS
659Head titubationFAERS: 1US FAERS
660Heat illnessFAERS: 1US FAERS
661Heavy exposure to ultraviolet lightFAERS: 1US FAERS
662HemiparesisFAERS: 1US FAERS
663HepatectomyFAERS: 1US FAERS
664Hepatic Vein ThrombosisFAERS: 1US FAERS
665Hepatic enzyme decreasedFAERS: 1US FAERS
666Hepatitis C RNA decreasedFAERS: 1US FAERS
667Hernia perforationFAERS: 1US FAERS
668Herpes Zoster OticusFAERS: 1US FAERS
669Herpes simplex pharyngitisFAERS: 1US FAERS
670High density lipoprotein increasedFAERS: 1US FAERS
671Hormone level abnormalFAERS: 1US FAERS
672Human chorionic gonadotropin positiveFAERS: 1US FAERS
673HydrocephalusFAERS: 1US FAERS
674HydronephrosisFAERS: 1US FAERS
675HyperkeratosisFAERS: 1US FAERS
676Hypertensive cerebrovascular diseaseFAERS: 1US FAERS
677HypertransaminasaemiaFAERS: 1US FAERS
678HypertrichosisFAERS: 1US FAERS
679Hypertrophy of tongue papillaeFAERS: 1US FAERS
680HypogeusiaFAERS: 1US FAERS
681Hypotonic-hyporesponsive episodeFAERS: 1US FAERS
682ImmunosuppressionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
683Impaired driving abilityFAERS: 1US FAERS
684ImpatienceFAERS: 1US FAERS
685Inability to afford medicationFAERS: 1US FAERS
686Incision site painFAERS: 1US FAERS
687Incorrect product administration durationFAERS: 1US FAERS
688Incorrect route of drug administrationFAERS: 1US FAERS
689Infected biteFAERS: 1US FAERS
690Infectious MononucleosisFAERS: 1US FAERS
691Injection site erythemaFAERS: 1US FAERS
692Injury associated with deviceFAERS: 1US FAERS
693Intervertebral Disc DegenerationFAERS: 1US FAERS
694Intervertebral disc injuryFAERS: 1US FAERS
695Intestinal Pseudo-ObstructionFAERS: 1US FAERS
696Intra-abdominal fluid collectionFAERS: 1US FAERS
697Intraocular pressure test abnormalFAERS: 1US FAERS
698Iron deficiencyFAERS: 1US FAERS
699Joint warmthFAERS: 1US FAERS
700Laboratory test interferenceFAERS: 1US FAERS
701Large intestine perforationFAERS: 1US FAERS
702Laryngeal discomfortFAERS: 1US FAERS
703Left Ventricular HypertrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
704LeukocytosisFAERS: 1US FAERS
705LeukoencephalopathyFAERS: 1US FAERS
706Ligament ruptureFAERS: 1US FAERS
707Lip and/or oral cavity cancerFAERS: 1US FAERS
708Lip exfoliationFAERS: 1US FAERS
709Liver carcinoma rupturedFAERS: 1US FAERS
710Liver function test decreasedFAERS: 1US FAERS
711Liver transplant rejectionFAERS: 1US FAERS
712Lupus NephritisFAERS: 1US FAERS
713LymphadenitisFAERS: 1US FAERS
714Lymphocyte count decreasedFAERS: 1US FAERS
715Lymphocyte count increasedFAERS: 1US FAERS
716Macular degenerationFAERS: 1US FAERS
717Malignant neoplasm progressionFAERS: 1US FAERS
718Malignant renal hypertensionFAERS: 1US FAERS
719Maternal exposure before pregnancyFAERS: 1US FAERS
720Maternal exposure during deliveryFAERS: 1US FAERS
721Mechanical acneFAERS: 1US FAERS
722Mechanical ventilationFAERS: 1US FAERS
723Melanoma recurrentFAERS: 1US FAERS
724MenopauseFAERS: 1US FAERS
725MetamorphopsiaFAERS: 1US FAERS
726MicroalbuminuriaFAERS: 1US FAERS
727Migraine with AuraFAERS: 1US FAERS
728MiliariaFAERS: 1US FAERS
729Miller Fisher SyndromeFAERS: 1US FAERS
730Miscarriage of partnerFAERS: 1US FAERS
731Monocyte count decreasedFAERS: 1US FAERS
732Mucinous adenocarcinoma of appendixFAERS: 1US FAERS
733Multiple sclerosis relapseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
734Mycobacterium tuberculosis complex test positiveFAERS: 1US FAERS
735MyocarditisFAERS: 1US FAERS
736MyositisFAERS: 1US FAERS
737NeurodermatitisFAERS: 1US FAERS
738Neurological decompensationFAERS: 1US FAERS
739Neutrophilic dermatosisFAERS: 1US FAERS
740New daily persistent headacheFAERS: 1US FAERS
741No adverse eventFAERS: 1US FAERS
742NocturiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
743Non-high-density lipoprotein cholesterol increasedFAERS: 1US FAERS
744Noninfective gingivitisFAERS: 1US FAERS
745Nonspecific reactionFAERS: 1US FAERS
746ObstructionFAERS: 1US FAERS
747Ocular discomfortFAERS: 1US FAERS
748OnychalgiaFAERS: 1US FAERS
749OnychoclasisFAERS: 1US FAERS
750Oral fungal infectionFAERS: 1US FAERS
751Oral infectionFAERS: 1US FAERS
752Oral mucosal exfoliationFAERS: 1US FAERS
753Oral pruritusFAERS: 1US FAERS
754PallorFAERS: 1US FAERS
755Palpatory finding abnormalFAERS: 1US FAERS
756ParapsoriasisFAERS: 1US FAERS
757Pathogen resistanceFAERS: 1US FAERS
758Pathological fractureFAERS: 1US FAERS
759Pelvic massFAERS: 1US FAERS
760Perihepatic discomfortFAERS: 1US FAERS
761Peripheral arterial occlusive diseaseFAERS: 1US FAERS
762PeritonitisFAERS: 1US FAERS
763Personality ChangeFAERS: 1US FAERS
764Phantom painFAERS: 1US FAERS
765Pharyngeal StenosisFAERS: 1US FAERS
766Physical deconditioningFAERS: 1US FAERS
767Physical product label issueFAERS: 1US FAERS
768PleurisyFAERS: 1US FAERS
769Pleuritic painFAERS: 1US FAERS
770PneumonitisFAERS: 1US FAERS
771Polyarteritis NodosaFAERS: 1US FAERS
772Polymerase chain reaction positiveFAERS: 1US FAERS
773Portal HypertensionFAERS: 1US FAERS
774Post procedural swellingFAERS: 1US FAERS
775Pre-EclampsiaFAERS: 1US FAERS
776Pre-existing condition improvedFAERS: 1US FAERS
777Pregnancy of partnerFAERS: 1US FAERS
778Pregnancy test false positiveFAERS: 1US FAERS
779Pregnancy with contraceptive deviceFAERS: 1US FAERS
780Prescription drug used without a prescriptionFAERS: 1US FAERS
781PriapismFAERS: 1US FAERS
782Primary Biliary CholangitisFAERS: 1US FAERS
783Procedural complicationFAERS: 1US FAERS
784Procedural site reactionFAERS: 1US FAERS
785Product coating issueFAERS: 1US FAERS
786Product distribution issueFAERS: 1US FAERS
787Product label issueFAERS: 1US FAERS
788Product measured potency issueFAERS: 1US FAERS
789Product shape issueFAERS: 1US FAERS
790Product substitution issueFAERS: 1US FAERS
791Product supply issueFAERS: 1US FAERS
792Prostatic specific antigen decreasedFAERS: 1US FAERS
793Protein total decreasedFAERS: 1US FAERS
794Pruritus allergicFAERS: 1US FAERS
795Psychiatric decompensationFAERS: 1US FAERS
796Psychiatric symptomFAERS: 1US FAERS
797Pulmonary arterial hypertensionFAERS: 1US FAERS
798Pulmonary painFAERS: 1US FAERS
799PyelitisFAERS: 1US FAERS
800PyelonephritisFAERS: 1US FAERS
801PyodermaFAERS: 1US FAERS
802Rectal abscessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
803RegurgitationFAERS: 1US FAERS
804Renal Cell CarcinomaFAERS: 1US FAERS
805Renal ColicFAERS: 1US FAERS
806Renal massFAERS: 1US FAERS
807Renal tubular necrosisFAERS: 1US FAERS
808Respiratory distressFAERS: 1US FAERS
809Retinal Vein OcclusionFAERS: 1US FAERS
810Rocky Mountain Spotted FeverFAERS: 1US FAERS
811RosaceaFAERS: 1US FAERS
812Schizoaffective DisorderFAERS: 1US FAERS
813Scrotal InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
814Scrotal irritationFAERS: 1US FAERS
815Seasonal Affective DisorderFAERS: 1US FAERS
816Secretion dischargeFAERS: 1US FAERS
817Semen analysis abnormalFAERS: 1US FAERS
818Semen volume decreasedFAERS: 1US FAERS
819Sensation of blood flowFAERS: 1US FAERS
820Sensorimotor disorderFAERS: 1US FAERS
821ShockFAERS: 1US FAERS
822Sinus TachycardiaFAERS: 1US FAERS
823Sinus operationFAERS: 1US FAERS
824Sjogren's SyndromeFAERS: 1US FAERS
825Skin WrinklingFAERS: 1US FAERS
826Skin irritationFAERS: 1US FAERS
827Skin lacerationFAERS: 1US FAERS
828Sleep TalkingFAERS: 1US FAERS
829Soft tissue necrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
830SoliloquyFAERS: 1US FAERS
831SomnambulismFAERS: 1US FAERS
832SoporFAERS: 1US FAERS
833Spinal fusion surgeryFAERS: 1US FAERS
834Splenic RuptureFAERS: 1US FAERS
835Spontaneous penile erectionFAERS: 1US FAERS
836Squamous cell carcinomaFAERS: 1US FAERS
837StaringFAERS: 1US FAERS
838Stomach scan abnormalFAERS: 1US FAERS
839Streptococcal endocarditisFAERS: 1US FAERS
840StridorFAERS: 1US FAERS
841Superficial vein prominenceFAERS: 1US FAERS
842Suture insertionFAERS: 1US FAERS
843Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
844Systemic mycosisFAERS: 1US FAERS
845TachyphreniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
846TensionFAERS: 1US FAERS
847Terminal stateFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
848Thermal burnFAERS: 1US FAERS
849Thoracic vertebral fractureFAERS: 1US FAERS
850Throat cancerFAERS: 1US FAERS
851Thrombocytopenic purpuraFAERS: 1US FAERS
852Tick-borne feverFAERS: 1US FAERS
853Tongue blisteringFAERS: 1US FAERS
854Tooth repairFAERS: 1US FAERS
855TorticollisFAERS: 1US FAERS
856Transaminases abnormalFAERS: 1US FAERS
857Transplantation complicationFAERS: 1US FAERS
858TrismusFAERS: 1US FAERS
859Troponin increasedFAERS: 1US FAERS
860TuberculosisFAERS: 1US FAERS
861Tympanic Membrane PerforationFAERS: 1US FAERS
862Umbilical herniaFAERS: 1US FAERS
863Unresponsive to stimuliFAERS: 1US FAERS
864Urethral dischargeFAERS: 1US FAERS
865Urine cannabinoids increasedFAERS: 1US FAERS
866Urine output increasedFAERS: 1US FAERS
867Vaginal DischargeFAERS: 1US FAERS
868Varicella Zoster Virus InfectionFAERS: 1US FAERS
869Venous thrombosis limbFAERS: 1US FAERS
870Viral load undetectableFAERS: 1US FAERS
871Vitreous degenerationFAERS: 1US FAERS
872Vitreous opacitiesFAERS: 1US FAERS
873Vulvovaginal burning sensationFAERS: 1US FAERS
874Vulvovaginal mycotic infectionFAERS: 1US FAERS
875Wheelchair userFAERS: 1US FAERS
876colonoscopyFAERS: 1US FAERS
877leiomyosarcomaFAERS: 1US FAERS
878pseudomembranous colitisFAERS: 1US FAERS
879Benign Prostatic HyperplasiaCanada Vigilance: 1Canada Vigilance
880CholestasisCanada Vigilance: 1Canada Vigilance
881Gastrointestinal bacterial overgrowthCanada Vigilance: 1Canada Vigilance
882Gastrointestinal infectionCanada Vigilance: 1Canada Vigilance
883Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
884Post procedural complicationCanada Vigilance: 1Canada Vigilance
885Wound ComplicationCanada Vigilance: 1Canada Vigilance
886angiogramCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.